Liquid Biopsy Biomarkers for Cervical Cancer: A Systematic Review
International Journal of Molecular Sciences · 29.10.2025 · 26 (21) · 10503
DOI: 10.3390/ijms262110503 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.10.2025. Verfasst von Jesús Alejandro Pineda-Migranas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Escuela Superior de Medicina, Instituto Politécnico Nacional (IPN), Salvador Díaz Mirón esq. Plan de San Luis y Díaz Mirón s/n, Col. Casco de Santo T…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cervical cancer remains a significant public health priority, particularly in low- and middle-income countries. In this context, liquid biopsy has emerged as a minimally invasive method for detecting and monitoring molecular biomarkers, offering advantages over traditional screening approaches. This systematic review included 21 studies published between 2015 and 2025 and was conducted in accordance with the PRISMA 2020 statement. The analysis examined the role of serum cytokines, circulating microRNAs (miRNAs), and circulating cell-free HPV DNA (cfHPV-DNA) in patients with cervical cancer or high-grade intraepithelial lesions. Circulating miRNAs—particularly miR-21, miR-29a, and miR-34a—are consistently associated with recurrence, tumor progression, and reduced survival. However, their immediate clinical translation remains limited by methodological variability and the lack of universal normalizers. In contrast, cfHPV-DNA, especially with ddPCR, exhibited the best study-level performance, with a specificity of 100% and a sensitivity of approximately 80–88%, across heterogeneous endpoints and analytic conditions. Consequently, cfHPV-DNA represents a promising tool for post-treatment surveillance and early detection of recurrence. Serum cytokines, such as TNF-α, IL-6, and IL-10, reflect inflammation and the tumor microenvironment. Nevertheless, their lack of standardization and variability across detection platforms restricts their reproducibility, positioning them as complementary rather than stand-alone markers. In conclusion, the evidence supports liquid biopsy as a promising tool in cervical cancer management; nonetheless, only cfHPV-DNA is currently ready for clinical application, whereas miRNAs and cytokines require multicenter validation and technical standardization before implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Escuela Superior de Medicina, Instituto Politécnico Nacional (IPN), Salvador Díaz Mirón esq. Plan de San Luis y Díaz Mirón s/n, Col. Casco de Santo Tomás, Mexico City 11340, Mexico.
- Health Research Unit, Hospital de Alta Especialidad Ixtapaluca, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Carr Federal México-Puebla Km 34.5, Ixtapaluca 56530, Mexic…
- Facultad de Medicina y Cirugía, Universidad Autónoma "Benito Juárez" de Oaxaca (UABJO), Oaxaca 68020, Mexico.
- Molecular Genetics and Diagnostic Laboratory, Hospital Juárez de México, Instituto Politécnico Nacional, 5160, Col. Magdalena de las Salinas, Mexico City 07760, Mexico.
- Research Division, Hospital Juárez de México, Instituto Politécnico Nacional, 5160, Col. Magdalena de las Salinas, Mexico City 07760, Mexico.
- Hospital General de México "Dr. Eduardo Liceaga", Eje 2A Sur (Dr. Balmis) No. 148, Cuauhtémoc, Doctores, Mexico City 06726, Mexico.
ORCID-Profile: Jesús Alejandro Pineda-Migranas, Juan Carlos Bravata-Alcántara, Iliana Alejandra Cortés-Ortíz, Enoc Mariano Cortés-Malagón, María de Los Ángeles Romero-Tlalolini, Mónica Sierra-Martínez, Gustavo Acosta-Altamirano
Zitieren
APA
Pineda-Migranas, J. A., Bravata-Alcántara, J. C., Cortés-Ortíz, I. A., Cortés-Malagón, E. M., de Los Ángeles Romero-Tlalolini, M., Sierra-Martínez, M., & Acosta-Altamirano, G. (2025). Liquid Biopsy Biomarkers for Cervical Cancer: A Systematic Review. International Journal of Molecular Sciences, 26(21), 10503. https://doi.org/10.3390/ijms262110503
Vancouver
Pineda-Migranas JA, Bravata-Alcántara JC, Cortés-Ortíz IA, Cortés-Malagón EM, de Los Ángeles Romero-Tlalolini M, Sierra-Martínez M, et al. Liquid Biopsy Biomarkers for Cervical Cancer: A Systematic Review. International Journal of Molecular Sciences. 2025;26(21):10503. doi:10.3390/ijms262110503
BibTeX
@article{PinedaMigranas2025,
author = {Pineda-Migranas, Jesús Alejandro and Bravata-Alcántara, Juan Carlos and Cortés-Ortíz, Iliana Alejandra and Cortés-Malagón, Enoc Mariano and de Los Ángeles Romero-Tlalolini, María and Sierra-Martínez, Mónica and Acosta-Altamirano, Gustavo},
title = {Liquid Biopsy Biomarkers for Cervical Cancer: A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {21},
pages = {10503},
doi = {10.3390/ijms262110503}
}
EUVIMED